Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
28°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bausch Health Companies Inc
(NY:
BHC
)
8.150
+0.030 (+0.37%)
Official Closing Price
Updated: 7:00 PM EST, Dec 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bausch Health Companies Inc
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day
December 05, 2024
Via
ACCESSWIRE
Bausch Health Appoints New Chief Medical Officer and Head of R&D
December 02, 2024
Via
ACCESSWIRE
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
November 18, 2024
Via
ACCESSWIRE
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
November 18, 2024
Via
ACCESSWIRE
Bausch Health Announces Third Quarter 2024 Results
October 30, 2024
Via
ACCESSWIRE
Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners
August 13, 2024
Via
ACCESSWIRE
Bausch Health Announces Second Quarter 2024 Results
July 30, 2024
Via
ACCESSWIRE
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
July 29, 2024
The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
November 01, 2024
Via
Benzinga
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
October 27, 2024
Via
ACCESSWIRE
Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt
October 26, 2024
IMG tennis assets are on the auction block. The announcement came after TKO inked a deal with Endeavor for Professional Bull Riders.
Via
Benzinga
Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags
October 21, 2024
S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day.
Via
Benzinga
Topics
Bankruptcy
Stocks
Exposures
Financial
Legal
US Equities
Bausch Health Responds to Market Rumors
July 24, 2024
Via
ACCESSWIRE
Bausch Health Welcomes Two New Members to the Executive Leadership Team
July 19, 2024
Via
ACCESSWIRE
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
October 14, 2024
Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb.
Via
Benzinga
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
October 09, 2024
Via
ACCESSWIRE
Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises
October 08, 2024
Via
ACCESSWIRE
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value
September 25, 2024
The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.
Via
MarketBeat
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
September 16, 2024
Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off.
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?
September 16, 2024
Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns.
Via
Investor's Business Daily
Bank Of Canada Cuts Rates Again As Inflation, Labor Market Cool: Canadian Stocks Rebound, Loonie Strengthens
September 04, 2024
Bank of Canada cuts key policy rate by 25 basis points to 4.25% and suggests further cuts if inflation continues to ease.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Bausch Health Solvency Remains A Concerns, Analyst Downgrades Stock
August 02, 2024
Bausch Health reports Q2 2024 GAAP EPS of $0.03, missing the consensus of $0.28. Revenue hits $2.403 billion, up 11% YoY. Piper Sandler downgrades BHC to Underweight with a price target of $3, citing...
Via
Benzinga
BHC Stock Plunges as Bausch Health Appears on the Brink of Bankruptcy
July 24, 2024
Although Bausch Health has denied rumors that it’s on the cusp of bankruptcy, BHC stock is nevertheless suffering from skepticism.
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
August 01, 2024
Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market...
Via
Benzinga
Why Bausch health Shares Are Falling Today
July 24, 2024
Bausch Health Companies Inc. (NYSE: BHC) is experiencing a sharp decline in its stock price Wednesday. The drop was triggered by a report suggesting the company is negotiating a potential prepackaged...
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
August 01, 2024
After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a...
Via
Benzinga
Stocks Plummet After Tech Earnings, Manufacturing Data
July 24, 2024
The Dow Jones Industrial Average is down triple digits, while the S&P 500 Index eyes its worst daily percentage drop since September 2023.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024
July 11, 2024
Via
ACCESSWIRE
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 24, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.